Anavex Life Sciences Corp (AVXL)

[Jonjones325]

Thank you investor, doc, Mayo, falconer and others for helping us layman interpret the poster and what it implies.

With each trial we get closer and closer that real precision medicine. The more data we get, the more we understand our MOA, the more indications we can target quickly and effectively.

With 3-71 up to bat next and the pathway of studying our platform being more clearly defined will help this company be a force in the CNS space for decades.

Hopefully there are enough high dose responders that improve, along with some mid dose responders that stabilize and/or decline slower than the SOC. IMO that will give us enough for AA. If not, at least we will know the next trial we be very close to a WGT trial.

The PDD trial was only 14 weeks, so hopefully the longer duration of the Alz trial can show greater effect.

Maybe now Missling and team can put the gas on the other trials using this data. Seems like an importance piece and one that was worth waiting for.